Brief: Anixa Biosciences And Moffitt Cancer Center Report U.S. FDA Request Of Additional Information For Car-T Therapy

Anixa Biosciences

19/04/2021 14:03

April 19 (Reuters) - Anixa Biosciences Inc  ANIX.O :
    * ANIXA BIOSCIENCES AND MOFFITT CANCER CENTER REPORT US FDA
REQUEST OF ADDITIONAL INFORMATION FOR CAR-T THERAPY
    * ANIXA BIOSCIENCES INC - STUDY UNDER IND APPLICATION HAS
BEEN
PLACED ON CLINICAL HOLD PENDING SUBMISSION OF ADDITIONAL
INFORMATION REQUESTED BY FDA
    * ANIXA BIOSCIENCES - WITHIN NEXT 30 DAYS, IT IS EXPECTED
THAT FDA
WILL PROVIDE LETTER TO MOFFITT CANCER CENTER WITH DETAILED,
SPECIFIC INFORMATION REQUESTED

Source text for Eikon:  ID:nPnbzGJDZa 
Further company coverage:  ANIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))